Allergan, Inc. (AGN) Reports In-Line Q4 EPS of $1.00; Guides Q1, FY12
Tweet
Share
E-mailGet Alerts AGN Hot Sheet
Price: $193.02 --0%
Financial Fact:
Restructuring charges: 185.5M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Restructuring charges: 185.5M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Allergan, Inc. (NYSE: AGN) reported Q4 EPS of $1.00, in-line with the analyst estimate of $1.00. Revenue for the quarter came in at $1.38 billion versus the consensus estimate of $1.41 billion.
Sees Q1 2012 EPS of $0.84-$0.86, versus the consensus of $0.91. Sees Q1 2012 revenue of $1.34-$1.39 billion, versus the consensus of $1.37 billion.
Sees FY2012 revenue of $5.65-$5.85 billion, versus the consensus of $5.89 billion.
For earnings history and earnings-related data on Allergan, Inc. (AGN) click here.
Sees Q1 2012 EPS of $0.84-$0.86, versus the consensus of $0.91. Sees Q1 2012 revenue of $1.34-$1.39 billion, versus the consensus of $1.37 billion.
Sees FY2012 revenue of $5.65-$5.85 billion, versus the consensus of $5.89 billion.
For earnings history and earnings-related data on Allergan, Inc. (AGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
- KULR Technology Group (KULR) Misses Q2 EPS by 39c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
